Antibody Combo ‘Reduces Mortality in Most Vulnerable COVID Patients’

RECOVERY trial reports that seronegative patients with COVID-19 were more likely to survive when given an infusion of two monoclonal antibodies than those offered only usual hospital care.

from Ob/Gyn & Women’s Health – Medscape http://www.medscape.com/viewarticle/953179
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started